Autor: |
Chenyang Duan, Li Wang, Jie Zhang, Xinming Xiang, Yue Wu, Zisen Zhang, Qinghui Li, Kunlun Tian, Mingying Xue, Liangming Liu, Tao Li |
Jazyk: |
angličtina |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
Redox Biology, Vol 37, Iss , Pp 101706- (2020) |
Druh dokumentu: |
article |
ISSN: |
2213-2317 |
DOI: |
10.1016/j.redox.2020.101706 |
Popis: |
Vascular dysfunctions such as vascular hyporeactivity following ischemic/hypoxic injury are a major cause of death in injured patients. In this study, we showed that treatment with mitochondrial division inhibitor 1 (Mdivi-1), a selective inhibitor of dynamin-related protein 1 (Drp1), significantly improved vascular reactivity in ischemic rats by attenuating oxidative stress. The antioxidative effects of Mdivi-1 were relatively Drp1-independent, and possibly due to an increase in the levels of the antioxidant enzymes, SOD1 and catalase, as well as to enhanced Nrf2 expression. In addition, we found that while Mdivi-1 had little effect on Drp1 GTPase activity in vascular smooth muscle cells, it inhibited hypoxia-induced Drp1 phosphorylation at Ser-616, reducing excessive mitochondrial fission and slightly enhancing mitochondrial fusion. These effects possibly contributed to vascular protection at an early stage of ischemic/hypoxic injury. Finally, Mdivi-1 stabilized hemodynamics, increased vital organ perfusion, and improved rat survival after ischemic/hypoxic injury, proving a promising therapeutic agent for ischemic/hypoxic injury. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|